// App-Quantinova.ai

63P : Clinical dysregulation of DNA repair by the polynucleotide kinase/phosphatase-XRCC4-DNA ligase IV in neurological disease

Researchers

Presenter

  • D.Aceytuno

Principal Investigators

  • C.G.Piett

  • Z.Havali-Shahriari

  • R.A.Edwards

  • M.Rey

  • R.S.Mani

  • S.Fang

  • M.Hammel

  • M.Weinfeld

  • J.A.Tainer

  • D.Schriemer

  • S.P.Lees-Miller

  • J.N.M.Glover

Medical Centers

  • Dept Chemistry, University of Alberta, Edmonton, AB, Canada

  • Biochemistry & Molecular Biology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada

  • Biochemistry and Molecular biology, University of Calgary, Calgary, Alberta, Canada

  • Cross Cancer Institute, Edmonton, AB, Canada

  • Molecular Biophysics & Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA

  • Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A